Exact Sciences Corporation

Ladies and gentlemen, thank you for standing by and welcome to the Exact Sciences first quarter 2021 earnings call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 on your telephone. If you require any further assistance, please press star 0. Thank you. I would now like to hand the conference over to your speaker today, Mr. Eric Holtzman, Senior Financial Analyst. Sir, please begin.

Thank you, Ren, and thank all of you for joining us for Exact Sciences' first quarter 2021 conference call. On the call today are Kevin Conroy, the company's Chairman and CEO, and Jeff Elliott, our Chief Financial and Chief Operating Officer. Exact Sciences issued a news release earlier this afternoon detailing our first quarter financial results. This news release and today's presentation are available on our website at exactsciences.com. During today's call, we will make forward-looking statements based on current expectations. Our actual results may be materially different from such statements. Reconciliations to GAAP figures are available in our earnings press release, and descriptions of the risks and uncertainties associated with Exact Sciences are included in our SEC filing. Both can be accessed through our website. It is now my pleasure to introduce the company's chairman and CEO, Kevin Conroy.

Thanks, Eric, and thanks to everyone for joining us this afternoon. The first quarter demonstrated Exact Sciences' commitment to eradicating cancer and the suffering it causes. Our talented team tested over 900,000 people during one quarter. Exact Sciences is a leader in cancer diagnostics because of our people, our scientific platforms, and our powerful brands, Cologuard and Ocotype. We're developing life-changing cancer solutions that will help patients. Today, we'll review our first quarter performance, full-year guidance, and progress on our 2021 priorities. I'd also like to congratulate Jeff Elliott on his well-earned promotion to Chief Operating Officer, in addition to his current CFO responsibilities. Jeff will now review our financial results.